DOI: https://doi.org/10.22141/2224-0551.5.48.2013.84744

Current Approaches to the Treatment of Acute Intestinal Infections in Children

L.V. Zakordonets, S.A. Kramarev, T.V. Beregovaya, A.N. Tolstanova, T.V. Dovbinchuk, A.V. Putnikov, T.M. Furzikova

Abstract


The article discussed in detail the following directions in the treatment of acute intestinal infections: rehydration, causal and supportive therapy. The indications to antibiotics in infectious diarrhea are given, attention was paid to use of probiotics.


Keywords


acute intestinal infections; diarrhea; treatment

References


WGO Practice Guidelines Acute diarrhea, 2008, http://www.who.int/mediacentre/factsheets/fs330/en/index.html

Guarino A., Albano F., Ashkenazi S. et al. Expert Working Group. The ESPGHAN/ESPID evidenced-based guidelines for the management of acute gastroenteritis in children in Europe // J. Pediatr. Gastroenterol. Nutr. — 2008. — 46(Suppl. 2). — P. 81-122.

Black R.E., Cousens S., Johnson H.L. et al. Global, regional, and national causes of child mortality in 2008: a systematic analysis // Lancet. — 2010. — Vol. 375. — P. 1969-1987.

Гострі кишкові інфекції у дітей / За ред. С.О. Крамарєва. — К.: Червона Рута Турс, 2007. — 132 с.

National Institute for Health and Clinical Excellence. Diarrhoea and vomiting in children. Diarrhoea and vomiting caused by gastroenteritis: diagnosis, assessment and management in children younger than 5 years. April 2009.

Managing acute gastroenteritis among children // MMWR (CDC). — 2003. — Vol. 52. — P. 1-16.

World Health Organization. The Treatment of diarrhoea: a manual for physicians and other senior health workers. — 4th rev. — Geneva, 2004.

Осипенко М.Ф., Бикбулатова Е.А., Холин С.И. Пробиотики в лечении диарейного синдрома // Фарматека. — 2008. — № 13. — C. 36-41.

Pothoulakis C., Kelly C.P., Joshi M.A., Gao N., O’Keane C.J., Castagliuolo I. Saccharomyces boulardiiinhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum // Gastroenterology. — 1993. — 104. — P. 1108-1115.

Buts J.P., Dekeyser N., Stilmant C., Delem E., Smets F. and Sokal E. Saccharomyces boulardii produces in rat small intestine a novel protein phosphatase that inhibits Escherichia coli endotoxin by dephosphorylation // Pediatr. Res. — 2006. — Vol. 60. — P. 24-29.

Janeway C.A., Travers P. Immunobiology. — 3rd ed. — Current Biology Ltd., Garland Publishing Inc., N.Y.; London, 1997.

Canonici A., Siret C., Pellegrino E., Pontier-Bres R., Pouyet L., Montero M.P., Colin C., Czerucka D., Rigot V., André F. Saccharomyces boulardii improves intestinal cell restitution through activation of the α2β1 integrin collagen receptor PLoS // One. — 2011. — Vol. 31. — P. 6-13.

Mumy K.L., Chen X., Kelly C.P., McCormick B.A. Saccharomyces boulardii interferes with Shigella pathogenesis by postinvasion signaling events // Am. J. Physiol. Gastrointest. Liver Physiol. — 2008. — Vol. 294. — P. 599-609.

Dahan S., Dalmasso G., Imbert V., Peyron J.F., Rampal P., Czerucka D. Saccharomyces boulardii interferes with enterohemorrhagic Escherichia coli-induced signaling pathways in T84 cells // Infect. Immun. — 2003. — Vol. 71. — P. 766-773.

Buts J.P. Twenty-five years of research on Saccharomyces boulardiit rophic effects: updates and perspectives // Dig. Dis. Sci. — 2009. — Vol. 54. — P. 15-18.

Girard-Pipau et al. Intestinal Microflora, Short-Chain and Cellular Fatty Acids, Influence of a Probiotic Saccharomyces boulardii // Microbial Ecology in Health and Disease. — 2002.

Heuvelin E., Lebreton C., Bichara M., Cerf-Bensussan N. and Heyman M. A Bifidobacterium probiotic strain and its soluble factors alleviate chloride secretion by human intestinal epithelial cells // Journal of Nutrition. — 2010. — Vol. 140. — P. 7-11.

Czerucka et al. Effect of Saccharomyces boulardiion cAMP-Ca2+-dependent Cl- secretion in T84 cells // Dig. Dis. Sci. — 1999. — Vol. 44. — P. 2359-2368.

Swartz T.D., Duca F.A., De Wouters T., Sakar Y., Covasa M. Up-regulation of intestinal type 1 taste receptor 3 and sodium glucose luminal transporter-1 expression and increased sucrose intake in mice lacking gut microbiota // British Journal of Nutrition. — 2012. — Vol. 107. — P. 621-630.

Buts J.P., Bernasconi P. Saccharomyces boulardii: Basic Science and Clinical Applications in Gastroenterology // Gastroenterol. Clin. N. Am. — 2005. — Vol. 34. — P. 515-532.

Van Baarlen P., Troost F., Van der Meer C., Hooiveld G., Boekschoten M., Brummer R.J., Kleerebezem M. Human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways // Proceedings of the National Academy of Sciences of the USA. — 2011. — Vol. 108, Suppl. 1. — P. 4562-4569.

Girard P., Pansart Y., Coppe M.C., Gillardin J.M. Saccharomyces boulardii inhibits water and electrolytes changes induced by castor oil in the rat colon // Dig. Dis. Sci. — 2005. — Vol. 50(11). — P. 2183-2190.

Allen S.J., Martinez E.G., Gregorio G.V. et al. Probiotics for treating acute infectious diarrhoea // Cochrane Database Syst. Rev. — 2010. — 11. — CD003048.

Riaz M., Alam S., Malik A., Ali S.M. Efficacy and safety of Saccharomyces boulardii in acute childhood diarrhea: a double blind randomised controlled trial // Indian. J. Pediatr. — 2012. — Vol. 79. — P. 478-482.

Corrêa N.B., Penna F.J., Lima F.M., Nicoli J.R., Filho L.A. Treatment of acute diarrhea with Saccharomyces boulardii in infants // J. Pediatr. Gastroenterol. Nutr. — 2011. — Vol. 53. — P. 497-501.

Francavilla R., Lionetti E., Castellaneta S. et al. Randomised clinical trial: Lactobacillus reuteri DSM 17938 vs. placebo in children with acute diarrhoea — a double-blind study // Aliment. Pharmacol. Ther. — 2012. — Vol. 36. — P. 363-369.

Бифидумбактерин форте в лечении острых кишечных инфекций у детей / Гаспарян М.О., Новокшонов А.А., Мацулевич Т.В. и др. // Детские инфекции на рубеже XXI века: настоящее и будущее. Всероссийская научно-практическая конференция. — 5–7 октября 1999 года. — C. 25.

Szajewska H., Skórka A. Saccharomyces boulardii for treating acute gastroenteritis in children: updated meta-analysis of randomized controlled trials // Aliment. Pharmacol. Ther. — 2009. — Vol. 30. — P. 955-63.

Dinleyici E.C., Eren M., Ozen M. Effectiveness and safety of Saccharomyces boulardii for acute infectious diarrhea // Expert Opin. Biol. Ther. — 2012. — Vol. 12. — P. 395-410.

Новокшонов А.А., Соколова Н.В., Бережкова Т.В., Ларина Т.С. Клиническая эффективность пробиотика «Энтерол» в комплексной терапии острых кишечных инфекций у детей // Детские инфекции: Научно-практический журнал Ассоциации педиатров-инфекционистов. — 2006. — Т. 5, № 2. — С. 43-47.




Copyright (c) 2016 CHILD`S HEALTH

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2018

 

   Seo анализ сайта